OR WAIT null SECS
The authors evaluated the potential of direct filtration for multiple biopharmaceutical candidates. This article is Part 2 of the study.
The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters.
SUS aids biopharma manufacturers to overcome the rigidity of more traditional stainless-steel technologies.
February 21, 2024
Webinar Date/Time: Wed, Mar 20, 2024 11:00 AM EDT
February 16, 2024
Webinar Date/Time: Thu, Mar 21, 2024 11:00 AM EDT
February 07, 2024
Purolite and Repligen have commercially launched a new CH1 affinity resin for the purification of specialized mAbs.
February 02, 2024
The authors present a methodology to assess the contribution of individual filters to overall capacity of the direct filtration train, and elucidate how capacity is affected by characteristics of the cell culture broth and process parameters, including for enhanced upstream processes such as those incorporating high cell density perfusion.
January 11, 2024
Webinar Date/Time: Thu, Feb 8, 2024 11:00 AM EST
January 01, 2024
Product and process understanding are essential to effective resin selection.
November 20, 2023
Webinar Date/Time: Wed, Dec 13, 2023 10:00 AM EST
November 15, 2023
Webinar Date/Time: Tuesday, December 12, 2023 Session 1: 9:00 am EDT | 1:00pm GMT | 2:00pm CET Session 2: 1:00 pm EDT| 12:00pm CDT| 10:00am PDT
November 13, 2023
Webinar Date/Time: Thu, Dec 14, 2023 11:00 AM EST